TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 1772-1777

  Bright, John J ^a   Sriram, Subramaniam ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GROWTH INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; JANUS KINASE 2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TYK2 KINASE; TYROSINE;

EID: 0032529220     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Trinchieri, G. 1994. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
2. Trinchieri, G. 1995. Interleukin 12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13:251.
3. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
4. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Dickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of NK cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
5. Bette, M., S. C. Jin, T. Germann, M. K. Schafer, E. Weihe, E. Rude, and B. Flaischer. 1994. Differential expression of mRNA encoding interleukin-12 p35 and p40 subunits in situ. Eur. J. Immunol. 24:2435.
6. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 184:741.
7. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, and A. Lanzavecchia. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
8. Shu, U., M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interactions. Eur. J. Immunol. 25:1125.
9. Constantinescu, C. S., K. Frei, M. Wysocka, G. Trinchieri, U. Malipiero, A. Rostami, and A. Fontana. 1996. Astrocytes and microglia produce interleukin 12 p40. Ann. NY Acad. Sci. 795:328.
10. Sriskandan, S., T. J, Evana, and J. Cohen. 1996. Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-γ. J. Immunol 156:2430.
11. 1 in PWM-stimulated PBMC and T cells. Immunology 91:354.
12. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, G. D. Sero, I. Nicoletti, G. Trinchieri, F. Bistoni, and P. Puccetti. 1997. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158:5349.
13. Kobayashi M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chang, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of NK cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827.
14. Maruo S., K. Toyo-oka, M. Oh-hora, X. G. Tai, H. Iwata, H. Takenaka, S. Yamada, S. Ono, T. Hamaoka, M. Kobayashi, M. Wysocka, G. Trinchieri, and H. Fujiwara. 1996. IL-12 production by antigen presenting cells induces IL-2-independent proliferation of T helper cell clone. J. Immunol. 156:1748.
15. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
16. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
17. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not IFN-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909.
18. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by IFN γ in monocytic cells. J. Exp. Med. 183:147.
19. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
20. Piermez, C. M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceicao-Silva, and R. L. Modlin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1390.
21. Sieling, P. A., and R. L. Modlin. 1994. Cytokine patterns at the site of mycobacterial infection. Immunobiology 191:378.
22. Zhang, M., M. K. Gately, E. Wang, J. Gong, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733.
23. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
24. Chougnet, C., T. A. Wynn, M. Clerici, A. L. Landay, H. A. Kessler, J. Rusnak, G. P. Melcher, A. Sher, and G. M. Shearer. 1996. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J. Infect. Dis. 174:46.
25. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro. Science 262:1721.
26. Pearlman, E. F., P. Heinzel, F. E. Hazlett, and J. W. Kazura. 1995. IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. J. Immunol. 154:4658.
27. Bright, J. J., B. F. Musuro, C. Du, and S. Sriram. 1998. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 82:22.
28. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of co-stimulatory molecules B7-1 (CD80), B7-2(CD86) and IL-12 in MS lesions. J. Exp. Med. 182:1985.
29. Tremblau, S., G. Penn, E. Posi, A. Mortara, M. K. Gately, and L. Adorini. 1995. IL-12 administration induces T helper type-I T cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
30. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181:381.
31. Neurath, M. F., I. Fuss, B. L. Kellsall, E. Stuber, and W. Trober. 1995. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281.
32. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and R. K. Assoian. 1986. Transforming growth factor-β: biological function and chemical structure. Science 233:532.
33. Rook, A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, M. B. Sporn, D. B. Burlington, H. C. Lane, and A. S. Fauci. 1986. Effects of TGF-β on the functions of NK cells: depressed cytolytic activity and blunting of IFN responsiveness. J. Immunol. 136:3916.
34. Fontana, A., K. Frei, S. Bodmer, E. Hoefer, M. H. Schreier, M. A. Palladino, and R. M. Zinkernagel. 1989. Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice. J. Immunol. 143:3230.
35. Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245.
36. Kehrl, J. H., L. M. Wakefield, A. Roberts, B. Jakowlew, S. M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of TGF β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
37. 1. J. Immunol. 142:4295.
38. Fox, F. E., R. J. Capocasale, H. C. Ford, R. J. Lamb, J. S. Moore, and P. C. Nowell. 1992. Transforming growth factor-β inhibits human T cell proliferation through multiple targets. Lymphokine Cytokine Res. 11:299.
39. + T cells requires the coordinate action of interleukin-12 and IFN-γ and is inhibited by TGF-β. Eur. J. Immunol. 24:793.
40. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-β inhibits IL-12-induced production of IFN-γ by NK cells: a role for TGF-β in the regulation of T cell independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994.
41. Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for NK cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
42. 1. J. Immunol 155:1066.
43. Pardoux, C., C. Asselin-Paturel, J. Chehimi, F. Gay, F. Mami-Chouaib, and S. Chouaib. 1997. Functional interaction between TGF-β and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J. Immunol 158:136.
44. 1. J. Immunol. 147:1792.
45. 2. J. Neuroimmunol. 46:175.
46. 1 in experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88:2918.
47. Chua, A. O., R. Chizzonite, B. B. Desai, T. P. Truitt, P. Nunes, L. J. Minetti, R. R. Warrier, D. H. Presky, and J. F. Levine. 1994. Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp 130. J. Immunol. 153:128.
48. Gubler, U., and D. H. Presky. 1996. Molecular biology of interleukin-12 receptors. Ann. NY Acad. Sci. 795:36.
49. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825.
50. 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
51. Bacon, C. M., E. F. Petricoin III, J. R. Ortaldo, R. C. Rees, A. C. Larner, J. A. Johnston, and J. J. O'Shea. 1995. Interleukin 12 induces tyrosine phosphorylation and activation of Stat 4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92:7307.
52. Bacon, C. M., D. W. McVicar, J. R. Ortaldo, R. C. Rees, and J. J. O'Shea, 1995. Interleukin-12 induces tyrosine phosphorylation of Jak-2 and Tyk-2: differential use of Janus tyrosine kinases by interleukin-2 and interleukin-12. J. Exp. Med. 181:399.
53. Bacon, C. M., S. S. Cho, and J. J. O'Shea. 1996. Signal transduction by interleukin-12 and interleukin-2. Ann. NY Acad. Sci. 795:41.
54. Jacobson, N. G., S. J. Szabo, R. M. Weber-Nordt, Z. Zhong, R. D. Schreiber, J. E. Darnell, and K. M. Murphy. 1995. Interleukin-12 signaling in Th1 cells involves tyrosine phosphorylation of Stat 3 and Stat 4. J. Exp. Med. 181:1755.
55. Su, X., and S. Sriram. 1992. Analysis of TCR Vβ gene usage and encephalitogenicity of myelin basic protein peptide p91-103 reactive T cell clones in SJL mice: lack of evidence for V gene hypothesis. Cell. Immunol. 141:485.
56. Bright, J. J., L. D. Kerr, and S. Sriram. 1997. TGF-β inhibits IL-2 induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J. Immunol. 159:175.
57. Argetsinger, L. S., X. Yang, A. Witthuhn, O. Silvennoinen, J. N. Ihle, and C. Carte-Su. 1993. Identification of Jak-2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237.
58. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945.
59. Oakes, S. A., F. Candotti, J. A. Johnston, Y. Chen, J. J. Ryan, N. Taylor, X. Liu, L. Hennighausen, L. D. Notarangelo, W. E. Paul, R. M. Blaese, and J. J. O'Shea. 1996. Signaling via IL-2 and IL-4 in Jak-3 deficient severe combined immunodeficiency lymphocytes: Jak-3 dependent and independent pathways. Immunity 5:605.
60. Darnell, J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
61. Ihle, J. N. 1996. Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Cancer Res. 68:23.
62. Wen, Z., Z. Zhong, and J. E. Darnell. 1995. Maximal activation of transcription by Stat 1 and Stat 3 requires both tyrosine and serine phosphorylation. Cell 82:241.
63. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massague. 1994. Mechanism of activation of the TGF-β receptor. Nature 370:341.
64. Massague, J. 1996. TGF-β signaling: receptors, transducers, and Mad proteins. Cell 85:947.
65. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E dependent kinase by TGF-β. Science 260:536.
66. Laiho, M., J. A. D. Caprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175.
67. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
68. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature 371:257.
69. 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur. J. Immunol. 24:1293.
70. Hunter, T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225.
71. Pazdrak, K., L. Justement, and R. Alarm. 1995. Mechanism of inhibition of eosinophil activation by TGF-β: inhibition of Lyn, MAP, Jak-2 kinase and Stat 1 nuclear factor. J. Immunol. 155:4454.
72. Panek, R. B., Y. Lee, and E. N. Benveniste. 1995. TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of Jak-1, Jak-2 or signal transducers and activators of transcription, or modification of IFN-γ enhanced factor X expression. J. Immunol. 154:610.